Skip to main content

Optimer Pharmaceuticals, Inc.


NASDAQ: OPTR

Investor Relations

Cases
Title Date Filed Updated Status Security
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) Investor Files Lawsuit Over Alleged Breaches Of Fiduciary Duties In Takeover 03/19/2021 Lawsuit Filed NASDAQ: OPTR